Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Jul 20,2018
Why Flu Recovery Is Slower for Women
The susceptibility and recovery from various pulmonary infections have been observed to have a sex bias, depending on the microbial pathogen. For instance, researchers have known that women, compared to men, tend to have more severe flu with slower recoveries even when their virus levels are the same. It had been thought that this wasRead more
More
Jul 19,2018
Leukemia Cells Take the Fast Track to the Nervous System
Acute lymphoblastic leukemia (ALL) in the central nervous system (CNS) is very difficult to treat, because most drugs are blocked from the organ system due to a "blood-brain barrier” (BBB) designed to protect the brain. How cancer cells enter the central nervous system has been an unanswered question for researchers and clinicians for decades.  Read more
More
Leukemia Cells Take the Fast Track to the Nervous System
Jul 19,2018
Cancer's Grip May Be Loosened by Tampering with DNA Clamp
To trip up fast-proliferating cancer cells, try throwing a wrench in their proliferation machinery, the aptly named proliferating cell nuclear antigen (PCNA). Wielding a new kind of wrench, a drug-like protein called a peptidomimetic ligand, scientists based at the University of Adelaide have jammed PCNA more effectively than scientists who have deployed more conventional drugs.Read more
More
Jul 18,2018
Weight-Loss Drug Looks to Spice Things Up
Anecdotal stories of spicy foods contributing to weight loss have circulated through the population for many years. In recent years, researchers have begun to tease out the molecular mechanisms that regulate the "hot” effect caused by peppers in the chili family – uncovering the possibility of some credence behind those weight loss stories.   Now,Read more
More
Jul 18,2018
Biomarker´s Potential for Diagnosing Traumatic Brain Injury Solidified
Traumatic brain injury (TBI) is characterized by impairments in cognition, emotion, or physical function caused by a violent blow to the head or direct brain penetration by an object. Upon injury, it is often difficult to evaluate the extent of damage or predict how long the impairment will last or whether it will worsen.
More
Biomarker´s Potential for Diagnosing Traumatic Brain Injury Solidified
Jul 17,2018
Fragile X Symptoms May be Helped with New Pharmacological Approach
Scientists report that a pharmacological strategy can alleviate multiple behavioral and cellular deficiencies in a mouse model of fragile X syndrome (FXS), the most common inherited form of intellectual disability and a major single-gene cause of autism spectrum disorders. The study ("Isoform-selective phosphoinositide 3-kinase inhibition ameliorates a broad range of fragile X syndrome-associated deficits in aRead more
More
Jul 17,2018
Cancer Drug Effectiveness Evaluated Using New Methodology
When it comes to anti-cancer drugs, it's not only their effectiveness at killing the intended target that we want to know, but also their ability to reach and penetrate the cancer cells. Researchers report the development of a technique that allows them to measure how well cancer drugs reach their targets inside the body.
More
Cancer Drug Effectiveness Evaluated Using New Methodology
Jul 16,2018
Human DNA Sentry Keeps Long Strands Atop Watch List
The human body is built for survival. Each one of its cells is closely guarded by a set of immune proteins armed with nearly foolproof radars that detect foreign or damaged DNA.   Out-of-place DNA arouses the suspicion of a mammalian protein called cGAS, or cyclic GMP-AMP synthase. Although cGAS is usually as passive asRead more
More
Human DNA Sentry Keeps Long Strands Atop Watch List
Jul 16,2018
Deletion of Addiction Gene Keeps Mice off Cocaine
Cocaine can have a devastating effect on people.  It directly stimulates the brain's reward center, and, more importantly, induces long-term changes to the reward circuitry that are responsible for addictive behaviors.   European researchers have discovered how a gene that has previously been implicated in cancer plays a key role in certain regions of theRead more
More
Jul 13,2018
Immunotherapy Boosts Survival Rates of Melanoma Brain Metastases' Patients
A team led by researchers at Brigham and Women's Hospital reports that checkpoint blockade immunotherapies provided significant improvements in overall survival for patients with melanoma brain metastases. Their results ("Improved Risk-Adjusted Survival for Melanoma Brain Metastases in the Era of Checkpoint Blockade Immunotherapies: Results from a National Cohort”) are published in Cancer Immunology Research.   "The successesRead more
More
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->